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Abstract
Background: The concept of vulnerability has held a central place in research ethics guidance since its introduction in
the United States Belmont Report in 1979. It signals mindfulness for researchers and research ethics boards to the
possibility that some participants may be at higher risk of harm or wrong. Despite its important intended purpose and
widespread use, there is considerable disagreement in the scholarly literature about the meaning and delineation of
vulnerability, stemming from a perceived lack of guidance within research ethics standards. The aim of this study was
to assess the concept of vulnerability as it is employed in major national and international research ethics policies and
guidelines.
Methods: We conducted an in-depth analysis of 11 (five national and six international) research ethics policies
and guidelines, exploring their discussions of the definition, application, normative justification and implications of
vulnerability.
Results: Few policies and guidelines explicitly defined vulnerability, instead relying on implicit assumptions and the
delineation of vulnerable groups and sources of vulnerability. On the whole, we found considerable richness in the
content on vulnerability across policies, but note that this relies heavily on the structure imposed on the data through
our analysis.
Conclusions: Our results underscore a need for policymakers to revisit the guidance on vulnerability in research ethics,
and we propose that a process of stakeholder engagement would well-support this effort.
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Background: the function of vulnerability in
research ethics guidance and policy
Research on human subjects is thought to be fundamen-
tally ethically challenging, requiring ethics standards to
guide researchers as well as approval and oversight of re-
search proposals from independent committees. Society
allows researchers to invite individuals to participate in re-
search once certain conditions are met, including a re-
search ethics board’s (REB, also known as Institutional
Review Boards, or IRBs, or Research Ethics Committees,
or RECs) determination that risks and benefits are
appropriately balanced, that the proposed strategy for sub-
ject recruitment is fair, and that voluntary, informed con-
sent will be sought from each potential subject [1]. The
concept of vulnerability, which finds it origins in the
United States Belmont Report of 1979 [2], plays a central
role in research ethics thinking, drawing attention to situ-
ations where these conditions may not be met [1]. Since
1979, the number of legal and non-legal research ethics
policies and guidelines has increased tremendously and,
with them, the use and scope of the concept of vulnerabil-
ity or vulnerable populations [2, 3]. However, there is
much scholarly disagreement over the appropriate mean-
ing and application of this concept in research ethics, and
policymakers are charged with the challenge of navigating
this contentious landscape in the development and refine-
ment of research guidelines and policies [4]. A growing
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body of literature critiques and aims to advance the way
vulnerability is conceptualised and employed in research
ethics, with major debates regarding foundational ele-
ments of this important ethical concept [5–10].
Major debates surrounding the concept of vulnerability in
research ethics
There is widespread agreement that some research par-
ticipants may be particularly vulnerable and in need of
special protections, yet the concept of vulnerability itself
has been described as ‘vague’ [11], with a lack of consen-
sus in the scholarly literature regarding the concept’s
central features. Contrasting accounts have been pro-
posed regarding the justification of vulnerability and
which ethical principles translate into obligations for the
special protection of vulnerable research participants.
Some accounts propose a justice-based reason for pro-
tection, concerned with the fairness of participant re-
cruitment and of the distribution of research burdens
and benefits [12, 13]. Others ground vulnerability in a
principle of autonomy or respect for persons, suggesting
that persons who cannot provide informed and volun-
tary consent are susceptible to harm because they are
not able to protect their interests [5, 13]. These ap-
proaches are not mutually exclusive, but we must at
least be able to identify which ethical principles define to
whom we owe special consideration. In research, there
are often gaps between the rules intended to govern and
the practices at hand, requiring those tasked with the
implementation of these rules to interpret and apply
them in their specific context [3]. An ethical foundation
is needed for these interpretations; otherwise, it is difficult
to understand the intentions of the authoring parties or
apply the rule to the situation at hand [3]. In this context,
a better understanding of the justifications of vulnerability
becomes a crucial goal of scholarly work in this area.
The application of vulnerability and its scope in re-
search has also been a subject of much debate. In par-
ticular, vulnerability has been charged with being both
too broad and too narrow. An overly broad concept cap-
tures all research participants, creating conceptual con-
fusion over the meaning of ‘special protections’, while an
overly narrow concept may leave some vulnerable partic-
ipants at risk and without the needed protection [5, 11,
12, 14]. Practically, a definition of vulnerability must be
comprehensive enough to capture those in need of add-
itional protections without overburdening participants
for whom protection beyond the norm is unnecessary.
Further, it must provide researchers and research ethics
boards with the information necessary to identify those
who are vulnerable, as well as what they might be vul-
nerable to. There are compelling arguments against nar-
row definitions of vulnerable groups that support the
identification of specific factors within the research con-
text and the participants’ personal situation that create
possible vulnerabilities [6].
The foundational debate about the concept of vulner-
ability revolves around its definition, with various pro-
posals made for its delineation in the literature. Arguing
that vulnerability lacks an organising principle, Hurst [5]
suggests that vulnerable persons are properly conceived
of as those who have “an identifiably increased likeli-
hood of incurring additional or greater wrong”. This ac-
count emphasises that both individual and situational
factors must be evaluated in defining vulnerability be-
cause being overly focused on individual characteristics
can obscure features of the research protocol or environ-
ment that may harm participants. Luna [6] argues that
vulnerability must be conceived of as ‘relational’, in that
vulnerabilities can only be discovered by examining an
individual in context, and ‘dynamic’, since one’s vulner-
ability depends on one’s context. Luna and Vanderpoel
[14] describe layers of vulnerability which arise from inter-
actions between an individual’s characteristics and their
environment, and which interact with one another to cre-
ate an inextricably context-dependent vulnerability.
To our knowledge, an in-depth analysis of the concept
of vulnerability as it exists in the policies and guidelines
that govern research on human subjects has not been
conducted. This is an important gap because, at present,
the scholarly literature seeks to advance the concept
without an understanding of the full scope of the regula-
tory context. Without a clear understanding of the con-
ceptualisation and operationalisation of vulnerability in
current research ethics, recommendations for its refine-
ment risk being disconnected from the range of policy
options. To explore the diversity of options with respect
to the enshrinement and application of the concept of
vulnerability in research ethics guidelines, we conducted
an in-depth analysis of major national and international
research ethics policies and guidelines.
Methods
Sampling
Inspired by previous research ethics policy analyses [3, 15],
we compiled a sample of internationally- and nationally-
adopted research ethics guidelines and policies, focusing on
Canada (the authors’ own regulatory context) and regions
with similar demographic and legal structures to Canada,
including Australia, the European Union, the United King-
dom, and the United States [15]. We began our search
using a compilation of international human research stan-
dards produced by the Office for Human Research Protec-
tions of the United States Department of Health and
Human Services [16]. Additionally, we performed second-
ary searches of the references of any included guidelines
and policies for relevant, non-duplicated documents.
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Our primary goal was to build a sample of guidelines
and policies that discussed or referenced vulnerability in
general health research. As such, we excluded those in
which vulnerability was not explicitly discussed (e.g. the
Nuremberg code) as well as those focused on specific
areas of or issues within research (e.g. paediatric research,
genetic research), put forward by professional organisa-
tions, or published as working papers, drafts, commentar-
ies, or otherwise less broadly adopted documents. Our
final sample included 11 guidelines and policies, six of
which are internationally-adopted (i.e. across multiple
countries) [17–22] and five of which are nationally-
adopted (i.e. within individual countries) [23–27]. All doc-
uments were downloaded and saved for data extraction.
See Table 1 for an overview of our sample and the key
characteristics of included policies.
Inter-policy component analysis
This stage of analysis consisted of an inter-policy analysis,
allowing us to capture and explore patterns in the data
across our sample. Given our specific interest in under-
standing how guidelines and policies employ the concept
of vulnerability, each document was word-searched for
the term ‘vulnerab’. Using this truncated keyword allowed
us to identify all uses of the terms ‘vulnerability’ or ‘vul-
nerable’. We read the broader sections of text surrounding
the key terms to facilitate a contextual understanding of
how the notion of vulnerability was used.
We employed a content analysis strategy, developing an
initial coding guide deductively and refining it inductively.
We hypothesised, based on the literature (as described in
the Background section), that research ethics guidance on
vulnerability should include at least the following basic con-
tent: (1) a definition of vulnerability, (2) a discussion of the
sources or circumstances from which vulnerability can arise
and/or identification of groups likely to be in those
circumstances, (3) an explanation of the ethical justification
of the concept to aid in its application. A preliminary
coding guide was created to capture these content areas.
This preliminary guide was applied to a subset of the sam-
ple (n = 3). Through this ‘piloting’ stage, the coding scheme
was refined inductively by three authors (DBR, EB, ER) to
ensure other major areas of content were captured. This re-
sulted in the addition of a fourth content category, ‘implica-
tions of vulnerability’, which captures responses to
vulnerable participants laid out within the guidelines and
policies. Definitions and rules for the application of each
code were developed to ensure rigor and thoroughness.
Throughout the coding process, three authors (DBR, EB,
ER) engaged in open discussions in order to account for
any biases of the primary coder (DBR) and to ensure the
full depth of the data would be represented through this
analytic strategy. Once final coding was complete, it was
reviewed by other authors (EB, ER, MEM) and consensus
was achieved through team discussions.
The results of our comparative data analysis are pre-
sented in tables, with direct excerpts from the guidelines
and policies provided where possible. Two codes (groups
and sources of vulnerability, and implications) included
more data than others and thus the text has been con-
densed (i.e. direct citations are not provided). To ensure
fidelity to the data, one author (DBR) condensed this
text and another (ER) reviewed it to ensure accurate rep-
resentation of the guidelines and policies.
Intra-policy holistic analysis
After the inter-policy comparative analysis, we examined
the conceptualisation and operationalisation of vulnerabil-
ity within each policy. Building on the structure developed
in our comparative analysis, we assessed the logical
consistency between the four content areas of vulnerabil-
ity. More specifically, we analyzed each policy and guide-
line in isolation to examine (1) which major content areas
are lacking, (2) whether the four content areas (definitions,
justifications, groups and sources, and implications) are con-
sistent (e.g. in their meaning) with one another, and (3) what
overall impression a guideline or policy user might have




All policies in our sample reference vulnerability and/or
vulnerable subjects, but only three out of eleven expli-
citly define these terms (Table 2). Of these, the Council
for International Organizations of Medical Sciences
(CIOMS) and the Tri-Council Policy Statement: Ethical
Conduct for Research Involving Humans (TCPS2) guide-
lines define vulnerability itself, while the International
Conference on Harmonisation, Good Clinical Practice
(ICH GCP) instead provides a definition of vulnerable
subjects. These definitions share similar structures, all de-
fining vulnerability or vulnerable subjects and identifying
paradigmatic sources (or causes) of vulnerability. The ICH
GCP definition focuses on issues of consent, where a lack
of voluntariness in a subject’s decision to participate estab-
lishes their vulnerability. The CIOMS and TCPS2 guide-
lines employ broader language, both stating that
vulnerability arises from a subject’s lack of ability to
protect their own interests. Both identify sources of vul-
nerability located within the subject (e.g. a lack of
decision-making capacity) and in their environment (e.g. a
lack of access to medical care). Only the definition pro-
vided by the TCPS2 makes explicit reference to another
central ethical concept – that of autonomy. This reference
suggests an important link between vulnerability and au-
tonomy, though this connection is not further explained.
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Table 1 Key characteristics of guideline and policy sample
Guideline/Policy Date Adopted Abbreviation Status Intended Users Guiding Ethical Framework/
Principles
Declaration of Helsinki 2013 Intl Declaration
of Helsinki
A statement of ethical
principles proposing how
physicians should act in
research; not legally binding
Primarily physicians; others
involved in medical research
with human subjects are
encouraged to adopt its
principles
Articles of the Declaration
itself are intended as








2002 Intl CIOMS A guidance document
intended to guide the
effective application of the
Declaration of Helsinki’s
ethical principles in

















A universal framework of
principles to guide States in
formulating legislation and
policies, as well as to guide





Addressed to States, but









Directive of 4 April 2001 N
°2001/20/EC
2001 EU EU Clinical
Trials
Directive
A legislative act that
establishes specific
provisions for good clinical
practice in clinical trials; EU
Member States must meet
these provisions though the
Directive does not legislate
how
EU member states Not explicitly provided;
states that “[t]he accepted
basis for the conduct of
clinical trials in humans is
founded in the protection of
human rights and the dignity
of the human being… as for
instance reflected in the 1996
version of the Helsinki
Declaration” [20]
Regulation of 16 April
2014 N°536/2014
2014 EU EU Clinical
Trials
Regulation
A binding legislative act
applying to all clinical trials
conducted in the EU












trials; serves as a unified
standard for CA, the EU,
JPN, and US to facilitate the
mutual acceptance of
clinical data by the
regulatory authorities in
these jurisdictions
Targeted at those involved
in the generation of clinical
trial data intended to be
submitted to regulatory
authorities, especially in CA,
the EU, JPN, and US; can
also be used by others
involved in clinical
investigations “that may
have an impact of the safety
and well-being of human
subjects” [22]
Not explicitly provided;
states that “clinical trials
should be conducted in
according with the ethical
principles that have their
origin in the Declaration of
Helsinki” ([22], Art. 2.1)
National Statement on





Must be used to inform the
design, ethical review, and
conduct of human research
funded by or taking place
under the auspices of the
bodies that have developed







ethical review bodies, and
those involved in research










2014 CA TCPS2 To be eligible to receive
and administer research
funds from the federal
research agencies
All those involved in the
conduct and review of
research funded by the
federal research agencies,
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The definition provided by the TCPS2 is distinct from
the others because it explicitly states that vulnerability is
context-dependent, and is experienced “to different
degrees and at different times, depending on [an individ-
ual’s or group's] circumstances” ([24], p. 210) . However,
qualifying language employed in other policies implicitly
suggests a similar view that vulnerability exists on a
spectrum or as a matter of degree (Table 2). The Declar-
ation of Helsinki, Australian National Statement, and
Belmont Report, for example, discuss participants who
are “particularly vulnerable” [17], “more-than-usually
vulnerable” [23], or “especially vulnerable” [26], re-
spectively. Unlike the TCPS2, no other guidelines in
our sample state explicitly that vulnerability should be
thought of as existing on a spectrum, or as a feature
that can vary between circumstances.
Ethical justifications for the concept of vulnerability
Many guidelines and policies (CIOMS, UNESCO
Declaration, Declaration of Helsinki, Australian National
Statement, TCPS2, Belmont Report) provide explicit ethical
argumentation relating to vulnerability and/or vulnerable
subjects. There is significant overlap across the sample be-
tween the principles from which obligations or consider-
ations relating to vulnerability arise (see Table 3 for an
overview). In all cases where guiding ethical principles are
provided by a policy or guideline, vulnerability-related con-
cerns are discussed in the application of each principle.
Table 1 Key characteristics of guideline and policy sample (Continued)
responsible for this policy
(i.e. Canadian Institutes of
Health Research, Natural
Sciences and Engineering




agree to comply with it;
while not required to do so,
other organisations and
entities are encouraged to
adopt this Policy to guide
the ethical aspects of the




ethics review boards, etc.
Research Governance
Framework for Health and
Social Care, 2nd edition
2005 UK UK Research
Governance
Framework
Sets out a framework of
principles, requirements,
and standards for the
governance of research in
health and social care and
applies to all research
relating to the
responsibilities of the
Secretary of State for Health
Intended for all those who
design research studies,







The Belmont Report 1979 US Belmont
Report
A statement of basic ethical
principles and guidelines
intended to assist in
resolving the ethical
problems that surround the
conduct of research created
by the National Commission
for the Protection of Human
Subjects of Biomedical and
Behavioral Research for the
Department of Health,
Education, and Welfare
Those involved in the
review and conduct of
research








Serves as a federal policy for
human subjects research,
and applies to all research
conducted or supported by
or affiliated with the federal
agencies by which is has
been adopted
Those involved in the
review and conduct of
research associated with the
federal agencies by which
the Common Rule has been
adopted
Not explicitly provided, but
the Regulations were
created on the basis of the
Belmont Report
Intl international, EU European Union, AUS Australia, CA Canada, JP Japan, UK United Kingdom, US United States
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The normative status of the concept of vulnerability is
inconsistent across policies and guidelines. In certain
cases (CIOMS, Australian National Statement, TCPS2,
Belmont Report), obligations towards vulnerable re-
search participants arise from the application of other
fundamental principles. For example, in the TCPS2, obli-
gations towards those in circumstances of vulnerability
are entailed by the policy’s core principles of Respect for
Persons, Concern for Welfare, and Justice. In others,
concerns or obligations related to vulnerability are them-
selves characterised as fundamental principles. Specific-
ally, principles 19 and 20 of the Declaration of Helsinki
focus on vulnerability, with 19 stating that “[s]ome groups
and individuals are particularly vulnerable and may have
an increased likelihood of being wronged or of incurring
additional harm” [17]. Similarly, Article 8 of the UNESCO
Declaration promotes “[r]espect for human vulnerability
and personal integrity” [19] as a principle in and of itself.
Table 2 Content regarding definitions of vulnerability and detailing the use of qualifying language
Policy/
Guideline




– • Some groups and individuals are “particularly vulnerable”
([17], Art. 19)
CIOMS “‘Vulnerability’ refers to a substantial incapacity to protect one’s
own interests owing to such impediments as lack of capability to
give informed consent, lack of alternative means of obtaining
medical care or other expensive necessities, or being a junior or
subordinate member of a hierarchical group” ([18], p. 18)
• Persons with serious, potentially disabling or life-
threatening diseases are “highly vulnerable” ([18], p. 65)
• Selection of the “least vulnerable” subjects required for
research ([18], p. 18)
UNESCO
Declaration
– • Certain individuals and groups are of “special










ICH GCP Glossary defines vulnerable subjects as “[i]ndividuals whose
willingness to volunteer in a clinical trial may be unduly influenced
by the expectation, whether justified or not, of benefits associated
with participation, or of a retaliatory response from senior members





– • Where “potential participants [in dependent or unequal
relationships] are especially vulnerable” special measures
may be required ([23], p. 53)
• Neonates in intensive care have a “unique developmental
vulnerability” ([23], p. 56)
• People with a cognitive impairment, intellectual
disability, or mental illness have “distinctive vulnerabilities
as research participants” and are “more-than-usually
vulnerable to various forms of discomfort or stress” ([23], p. 58)
CA TCPS2 “Vulnerability – A diminished ability to fully safeguard one’s own
interests in the context of a specific research project. This may be
caused by limited decision-making capacity or limited access to
social goods, such as rights, opportunities and power. Individuals
or groups may experience vulnerability to different degrees and
at different times, depending on their circumstances. See also ‘Au-
tonomy’” ([24], p. 210)
• Participants, researchers, and research ethics board
members may be rendered “more vulnerable” during
publicly declared emergencies ([24], p. 90)
• “The least organisationally developed communities are the
most vulnerable to exploitation” ([24], p. 130)
• Participants may be “in highly vulnerable circumstances”







– • “Also, inducements that would ordinarily be acceptable
may become undue influences if the subject is especially




aQualifying language captures nuances about degrees or types of vulnerability
Intl international, EU European Union, AUS Australia, CA Canada, JP Japan, UK United Kingdom, US United States, CIOMS Council for International Organizations of
Medical Sciences, TCPS2 Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans, ICH GCP International Conference on Harmonisation, Good
Clinical Practice
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The CIOMS guidelines are a unique case in our sample
because they characterise vulnerability as both a principle
and as a consideration derived from other principles. In
the introduction to the CIOMS guidelines, issues of
human rights are described as relating to two principles,
one of which is the “protection of dependent or vulnerable
persons and populations” ([18], p. 11), while the principle
of Respect for Persons is described as entailing “at least
two fundamental ethical considerations”, including “pro-
tection of persons with impaired or diminished autonomy,
which requires that those who are dependent or vulnerable
be afforded security against harm or abuse” ([18], p. 17).
In the remaining guidelines (ICH GCP, EU Clinical
Trials Directive, EU Clinical Trials Regulation, United
Kingdom Research Governance Framework, Common
Rule), vulnerability is not explicitly discussed in relation
to any ethical principles, nor is it described as a guiding
principle itself. In these cases, concerns relating to vul-
nerable persons seem to serve the role of consideration
for ethics review or ethical research with no explicit
ethical status.
Identifying vulnerable groups and individuals
All guidelines and policies in the sample provide means
through which vulnerability can be identified. The ma-
jority identify subject groups who are likely to be
vulnerable. Vulnerable groups identified in our sample
are captured in Table 4, along with the corresponding
explanations of why a subject group is considered vul-
nerable or what they are vulnerable to, when these de-
tails are available. Notably, while the EU Clinical Trials
Directive and Clinical Trials Regulation, as well as the
United Kingdom Research Governance Framework, all
identify vulnerable subject groups, none of these policies
provide any supporting explanation. Further, only four
policies (CIOMS, Australian National Statement, TCPS2,
and the Common Rule) provide any explanations of
what certain identified groups are vulnerable to.
Across the sample, a great number of groups are iden-
tified as vulnerable. Counting only those broad groups
identified in our table (i.e. excluding the examples of
subgroups discussed in the footnote to Table 4), 32
groups were identified; when these subgroups are in-
cluded, the total number of groups identified as vulner-
able expands to 51. Groups most frequently identified
are children, minors or young people (discussed in seven
policies), prisoners (discussed in five policies), as well as
persons with mental health issues, patients in emergency
settings, and certain ethnocultural, racial or ethnic mi-
nority groups (each discussed in four policies). Concerns
for the vulnerability of children centre around consent,
with both the CIOMS and TCPS2 guidelines positing a
Table 3 Content on the ethical justification of vulnerability and its normative status in each policy
Policy/Guideline Justification for vulnerability Normative status of vulnerability
Intl
Intl
ICH GCP – Consideration for ethics review
CIOMS The protection of dependent or vulnerable persons and populations is described itself as a
principle; additionally, concerns relating to vulnerability are grounded in both the principles
of respect for persons and justice
Fundamental principle/
application of other principles
UNESCO
Declaration









– Consideration for ethics review
Clinical Trials
Regulation





Considerations related to vulnerability are discussed in relation to the principles of principles
of respect for persons, research merit and integrity, justice, and beneficence
Application of other principles
CA
TCPS2 The principles of respect for persons, justice (fairness and equity), and concern for welfare all
entail special obligations regarding vulnerability





– Consideration for ethics review
US
Belmont Report The principles of respect for persons, beneficence, and justice all entail special obligations
relating to vulnerability
Application of other principles
Common Rule – Consideration for ethics review
Intl international, EU European Union, AUS Australia, CA Canada, JP Japan, UK United Kingdom, US United States, CIOMS Council for International
Organizations of Medical Sciences, TCPS2 Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans, ICH GCP International Conference
on Harmonisation, Good Clinical Practice
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Table 4 Vulnerable groups identified in our sample, as well as explanations for this designation, where available
Vulnerable Group (Mentioned in) Explanation
Grouped by social status or situation
Prisoners (CIOMS, ICH GCP, Aus. National
Statement, TCPS2, Common Rule)
Vulnerable because:
• Historically considered vulnerable and “have, at times,
been treated unfairly and inequitably in research, or have
been excluded from research opportunities”a ([24], p. 8)
• Explanation unclear [18, 22]
Vulnerable to:
• Coercion or undue influence [27]
Certain ethnic, racial minority, or ethnocultural
groups (CIOMS, ICH GCP, TCPS2, Belmont Report)
Vulnerable because:
• Historically considered vulnerable and “have, at times,
been treated unfairly and inequitably in research, or
have been excluded from research opportunities”a ([24], p. 8)
• May continually be sought as research subjects due to ready
availability and administrative convenience; have a dependent
status and, frequently, compromised capacity for free consent;
are easy to manipulate as a result of their illness or socioeconomic
condition b[26]
• Explanation unclear [18, 22]
Patients in emergency settings, prospective
participants for emergency research (CIOMS,
Clinical Trials Regulation, ICH GCP, TCPS2)
Vulnerable because:
• Their incapacity to make decisions creates vulnerable
circumstances [24]
• No explanation [21]
• Explanation unclear [18, 22]
Subordinate members of hierarchies or relationshipsc
(CIOMS, ICH GCP, Aus. National Statement)
Vulnerable because:
• Voluntary consent may be compromised by expectations
of benefit or repercussions from superiors [18, 22]
• Pre-existing relationships may compromise the voluntariness
of consent because they typically involve unequal status, where
one party has influence or authority over the other [23]
Vulnerable to:
• Being over-researched [18, 23]
Economically disadvantaged persons
(Belmont Report, Common Rule)
Vulnerable because:
• Dependent status, impaired capacity to consent, easy to
manipulate as a result of their illness [26]
Vulnerable to:
• Coercion or undue influence [27]
Homeless persons (CIOMS, ICH GCP) • Explanation unclear [18, 22]
Institutionalized persons (TCPS2, Belmont Report) Vulnerable because:
• Historically considered vulnerable and “have, at times, been treated
unfairly and inequitably in research, or have been excluded from
research opportunities”a ([24], p. 8)
• Their ability to fully safeguard their own interests in research may
be limited, and their situation may compromise the voluntariness
of consent in other ways [24]
• May continually be sought as research subjects due to ready availability
and administrative convenience; have a dependent status and, frequently,
compromised capacity for free consent; are easy to manipulate as a result
of their illness or socioeconomic conditionb [26]
Nomads (CIOMS, ICH GCP) • Explanation unclear [18, 22]
Persons in nursing homes (CIOMS, ICH GCP) • Explanation unclear [18, 22]
Persons lacking political or social power (CIOMS) • Explanation unclear [18]
Refugees or displaced persons (CIOMS, ICH GCP) • Explanation unclear [18, 22]
Women (CIOMS, TCPS2) Vulnerable to:
• In some parts of the world, they may be vulnerable to neglect or harm
in research “because of their social conditioning to submit to authority,
to ask no questions, and to tolerate pain and suffering” ([18], p. 73)
Vulnerable because:
• Historically considered vulnerable and “have, at times, been treated
unfairly and inequitably in research, or have been excluded from
research opportunities”a ([24], p. 8)
Bracken-Roche et al. Health Research Policy and Systems  (2017) 15:8 Page 8 of 18
Table 4 Vulnerable groups identified in our sample, as well as explanations for this designation, where available (Continued)
Countries or communities with limited resources (CIOMS) Vulnerable to:
• Exploitation by sponsors and investigators who are relatively wealthy [18]
Educationally disadvantaged persons (Common Rule) Vulnerable to:
• Coercion or undue influence [27]
Members of communities unfamiliar with modern
medical concepts (CIOMS)
• Explanation unclear [18]
Neonates in intensive care (Aus. National Statement) Vulnerable because:
• Developmental vulnerability (potential for long-range impacts on
health and development) [23]
Patients in terminal care (Aus. National Statement) Vulnerable to:
• Unrealistic expectations of benefit [23]
Participants and researchers in research that uncovers
illegal activities (Aus. National Statement)
Vulnerable because:
• Vulnerability may arise because of discovery of participants’
illegal activity [23]
Those with diminished capacity for self-determination (TCPS2) • Historically vulnerable and “have, at times, been treated unfairly
and inequitably in research, or have been excluded from research
opportunities”a ([24], p. 8)
The least organizationally developed communities (TCPS2) Vulnerable to:
• Exploitation [24]
Grouped by patient/participant condition
Children, minors, or young people (CIOMS, Clinical
Trials Directive, Clinical Trials Regulation, Aus. National
Statement, TCPS2, Common Rule)
Vulnerable because:
• Limited freedom or capacity to consent [18, 24]
• Vulnerability arising from developmental stage [24]
• No explanation [20, 21]
• Explanation unclear [23]
Vulnerable to:
• Coercion or undue influence [27]
Persons with mental illness or mental health problems
(Clinical Trials Regulation, Aus. National Statement,
TCPS2, UK Research Governance Framework)
Vulnerable because:
• Historically considered vulnerable and “have, at times,
been treated unfairly and inequitably in research, or
have been excluded from research opportunities”a ([24], p. 8)
• Unclear [21, 25]
Vulnerable to:
• Various forms of discomfort and stress [23]
Elderly persons (CIOMS, Clinical Trials Regulation, TCPS2) Vulnerable because:
• Likely to acquire “vulnerability-defining” traits (e.g., institutionalization,
dementia) ([18], p. 65]
• Historically considered a group in vulnerable circumstances “have, at
times, been treated unfairly and inequitably in research, or have been
excluded from research opportunities”a ([24], p. 8)
• No explanation [21]
Persons with limited (or no) freedom or capacity
to consent (CIOMS, Clinical Trials Regulation, ICH GCP)
Vulnerable because:
• Relatively (or absolutely) incapable of protecting their own interests [18]
• No explanation [21]
• Explanation unclear [22]
Vulnerable to:
• Exploitation for financial gain by guardians [18]
Pregnant or breastfeeding women (Clinical Trials
Regulation, Common Rule)
Vulnerable to:
• Coercion or undue influence [27]
• No explanation [21]
Adults with learning difficulties (UK Research
Governance Framework)
• No explanation [25]
Handicapped persons (Common Rule) • No explanation [27]
Mentally disabled persons (Common Rule) Vulnerable to:
• Coercion or undue influence [27]
Persons who have serious, potentially disabling or
life-threatening diseases (CIOMS)
Vulnerable because:
• May be treated with drugs or other therapies with unproven
safety and efficacy [18]
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vulnerability arising from their limited freedom or cap-
acity to consent and the Common Rule emphasising
children’s vulnerability to coercion or undue influence.
The Australian National Statement similarly positions
the vulnerability of young people relative to capacity and
consent, though it is unclear how this policy conceives
of the relationship between these concepts. It outlines
various scenarios regarding the vulnerability of young
people: in some cases, young people may be able to
understand information but their “relative immaturity
means they remain vulnerable” ([23], p. 50); in other
cases they may be “mature enough to understand and
consent [though] not vulnerable through immaturity in
ways that warrant additional consent” ([23], p. 50); and
in yet other cases, young people may be “mature enough
to understand the relevant information and to give con-
sent, although vulnerable because of immaturity in other
respects” ([23], p. 50). The ‘other respects’ in which im-
maturity can render young people vulnerable are not
made explicit, leaving the designation of vulnerability
open to interpretation in this case. Other policies employ
similarly open-ended strategies, the CIOMS guidelines
most explicitly by listing vulnerable groups and sources of
vulnerability, and adding that “[t]o the extent that these
and other classes of people have attributes resembling
those of classes identified as vulnerable, the need for spe-
cial protection of their rights and welfare should be
reviewed and applied, where relevant” ([18], p. 65).
There is little overlap between the explanations provided
by policies and guidelines for other frequently-identified
vulnerable groups, and there was a lack of explanation from
at least two of them for prisoners, patients in emergency
settings, and ethnocultural and racial minorities. For over
half of the groups identified across our sample, an explan-
ation of their vulnerability was unclear or lacking entirely.
The EU Clinical Trials Directive and Clinical Trials Regula-
tion and United Kingdom Research Governance Frame-
work provide no explanation or justification for any of the
groups they designate as vulnerable, and while the Com-
mon Rule specifies that it is concerned with vulnerability to
coercion or undue influence, it does not address 'handi-
capped persons' in this explanation despite also identifying
them as a vulnerable subject group. The CIOMS and ICH
GCP guidelines, on the other hand, provide definitions of
vulnerable subjects and explanations for some vulnerable
groups. However, both of these policies include categories
of 'other vulnerable groups' and fail to provide any connec-
tion between these other groups and their overarching def-
inition of vulnerability. As such, it is unclear whether they
are designated as vulnerable on some other unstated
grounds.
Some policies and guidelines identify sources or
circumstances of vulnerability independently, i.e. without
any relation or association to a specific vulnerable group.
For example, neither the Declaration of Helsinki nor the
UNESCO Declaration identifies any particular subject
groups as vulnerable. Instead, they identify characteris-
tics of vulnerable participants or key sources of vulner-
ability (Table 5). It is important to note that, while the
TCPS2 does identify certain groups as likely to be in vul-
nerable circumstances, it qualifies any such labels,
emphasising that “[i]ndividuals should not automatically
be considered vulnerable simply because of assumptions
made about the vulnerability of the group to which they
belong” ([24], p. 54).
Implications of vulnerability in research
All policies in our sample identify practical implications
of vulnerability in research, i.e. responses to vulnerability
in the design and review of research and to vulnerable
Table 4 Vulnerable groups identified in our sample, as well as explanations for this designation, where available (Continued)
Very sick persons (Belmont Report) Vulnerable because:
• May continually be sought as research subjects due to ready
availability and administrative convenience; have a dependent status
and, frequently, compromised capacity for free consent; are easy to
manipulate as a result of their illness or socioeconomic conditionb [26]
People suffering from multiple chronic conditions (Clinical Trials
Regulation)
• No explanation [21]
Persons with a cognitive impairment or intellectual disability
(Aus. National Statement)
Vulnerable to:
• Various forms of discomfort and stress [23]
aIt is not clear whether the TCPS2 intends these groups it refers to as having been historically in vulnerable circumstances as still at risk of this. Given that this is
mentioned but not negated, we included these groups in our table
bThe Belmont Report lists a number of vulnerable groups and a series of explanations of their vulnerability. It is unclear whether certain groups were intended to
be linked to certain explanations, so all have been included
cWithin this category, specific subject groups are provided as examples. For the CIOMS these are “medical and nursing students, subordinate hospital and
laboratory personnel, employees of pharmaceutical companies, and members of the armed forces or police” ([18], p. 65). The ICH GCP adds pharmacy and dental
students and persons kept in detention to this list [18]. The Australian National Statement lists “carers and people with chronic conditions or disabilities, including
long-term hospital patients, involuntary patients, or people in residential care or supported acumination; health care professionals and their patients or clients;
teachers and their students; prison authorities and prisoners; governmental authorities and refugees; employers or supervisors and employees (including
members of the Police and Defence forces); service-providers (government or private) and especially vulnerable communities to whom the service is provided”
([23], p. 53).
The table is grouped by category, and organized by the number of times a group is mentioned in the policies and guidelines
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participants themselves. A wide range of implications
were identified, some directed explicitly towards REBs
and/or investigators but the majority formulated more
broadly with no specific group targeted. Further, these
implications span the research process, from consider-
ations important in the design of research to actions that
must be taken when vulnerable persons are participating
in research (Table 6).
A majority of policies and guidelines identify implica-
tions relating to restrictions for research with vulnerable
groups or individuals, but these entail both negative and
positive duties. Overall, these policies and guidelines
propose that the involvement of vulnerable groups in re-
search ought to be restricted to some extent; vulnerable
persons ought to be involved only when the research
cannot be carried out with persons who are less vulner-
able and special justification is required for their involve-
ment. However, when these persons are involved in
research, additional actions are required, such as the de-
sign of research that is responsive to their needs or pri-
orities and the provision of benefits relevant to their
group/subject population. Across our sample, a common
underlying assumption seems to be that vulnerable
groups can and should be involved in research, but that
additional measures are required to ensure this involve-
ment occurs in an ethical manner. In fact, several pol-
icies (CIOMS, EU Clinical Trials Directive, Australian
National Statement, and TCPS2) assert that vulnerable
groups have a right to participate in research and access
its benefits, and while the others do not identify such an
entitlement, none go so far as to state that the outright
exclusion of vulnerable groups from research best serves
to protect them.
The implications of vulnerability all tend towards careful
inclusion rather than outright exclusion of vulnerable
groups from research. However, there is more variability re-
garding the extent to which these protections afford agency
to vulnerable subjects. The majority specify considerations
and actions for researchers and REBs, with few explicitly
identifying the desires of these individuals as relevant in the
application of these measures. The TCPS2 in particular
puts forth numerous measures intended to promote the
agency of those in vulnerable circumstances. For example,
it is suggested that they should be afforded opportunities to
influence research and that research ought to enhance vul-
nerable persons’ capacity for participation. Furthermore,
the TCPS2 guidance states more broadly that vulnerable
groups may need or desire special measures to ensure their
safety, suggesting a role for participants in the design and
implementation of their protections.
In addition to conditions and restrictions for research
involvement, the process of informed consent is a major
area of focus in the policies and guidelines. Here in par-
ticular there is an emphasis on the provision of mean-
ingful support to enable vulnerable persons to offer a
fully informed consent to research. Mechanisms of sup-
port include ensuring adequate time and an appropriate
environment (CIOMS), as well as ensuring that informa-
tion is fully explained and understood (United Kingdom
Research Governance Framework). Additionally, the
Australian National Statement uniquely suggested that
participants be given the option of using a participant
advocate within the consent process.
Holistic policy analysis
Of the 11 policies and guidelines in our sample, only
two, the CIOMS guidelines and TCPS2, meet our cri-
teria for a full conceptualisation of vulnerability, ad-
dressing all content areas (Table 7). In this section, we
present the results of our intra-policy analysis of vulner-
ability with a narrative about each policy statement, ad-
dressing (1) which major content areas are lacking, (2)
whether the content areas are consistent (i.e. in their
meaning) with one another, and (3) what overall impres-
sion a guideline or policy user might have about the
concept of vulnerability within the document.
International policies and guidelines
Declaration of Helsinki The Declaration conveys a
harm/wrong-based conceptualisation of vulnerability
that is internally coherent due to its broad language. It
does not identify what these wrongs or harms might
consist of and, because concern for vulnerability is pre-
sented as a fundamental principle, interpretation cannot
be guided by other ethical principles. Implications of
vulnerability focus on the need for responsive research,
special justification for involving vulnerable persons, and
to-group benefits, suggesting these harms include the
unfair distribution of the risks and benefits of research.
CIOMS These guidelines present an autonomy-based
conceptualisation of vulnerability that is comprehensive
in scope but lacks internal clarity in its discussion of
Table 5 Sources of vulnerability identified independently from
vulnerable groups
Policy/Guideline Sources of vulnerability
Declaration of
Helsinki




Persons may be rendered vulnerable by disease or
disability or other personal, societal or environmental
conditions
TCPS2 Persons may be in vulnerable circumstances because
of social or legal stigmatisation associated with their
activity or identity
TCPS2 Tri-Council Policy Statement: Ethical Conduct for Research
Involving Humans
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Table 6 Implications of vulnerability, grouped by theme
Restrictions for research with vulnerable groups
or individuals
Policy/Guideline
When research is carried out with vulnerable
participants it should be responsive to the




Vulnerable subjects should be involved in
research only when it cannot be carried out
with less vulnerable subjects
CIOMS
Special justification is required for involving
vulnerable groups in research and
appropriateness ought to be demonstrated
CIOMS;
Belmont Report
Children should not be included in early-phase
research until therapeutic effects have been
shown in adults
CIOMS
Opportunities to participate in and influence
research affecting their welfare should not be
withheld from vulnerable groups
TCPS2
Members of vulnerable groups are entitled to
access the benefits of research
CIOMS
Children must be involved in studies of




People with a cognitive impairment,
intellectual disability, or mental illness are
entitled to participate in research, which need




Research with communities vulnerable to
exploitation should strive to enhance capacity
for participation
TCPS2
Patients receiving high-risk clinical care should
not be inappropriately included in or excluded
from research
TCPS2
Risk to vulnerable subjects is justified when it
arises from interventions that will provide a
direct health benefit, or when it will benefit
the subject’s population group
CIOMS
Special protections and obligations
Individuals and groups of special
vulnerability should be protected
UNESCO Declaration
Special ethical obligations exist towards
vulnerable subjects
TCPS2
Vulnerable subjects should receive special/
specific protections
Declaration of Helsinki
Groups or individuals in vulnerable
circumstances may need or desire special
measures to ensure their safety in a specific
research project
TCPS2
Vulnerable subjects should be afforded
security against harm or abuse
CIOMS
Special (or additional) protections for the




Special attention should be paid to trials
involving vulnerable subjects
ICH GCP
Table 6 Implications of vulnerability, grouped by theme
(Continued)
Special attention or regard should be paid
to vulnerable communities, groups, or persons
UNESCO Declaration;
TCPS2
Researchers and REBs should recognise and
address changes in participants’ circumstances
that may impact their vulnerability
TCPS2
Research ethics board composition
REBs reviewing research with vulnerable
subjects should include members with




Community members on REBs ought to
reflect participant’s perspectives, particularly
important when participants are vulnerable
and/or risks are high
TCPS2
Assessing harms, risks and benefits
For those gauging the severity of harm in




The existence of vulnerable circumstances
may require greater effort to minimise risks/
maximise benefits to participants
TCPS2
Care must be taken to ensure the risks and
burdens of proposed research with persons
with a cognitive impairment, intellectual





The vulnerability of persons in unequal,
dependent relationships must be taken into
account when considering recruiting these
persons
National Statement
Process of informed consent
Consent may need to be re-confirmed in re-
search where participants are vulnerable
National Statement
The method of consent in qualitative
research depends, in part, on the vulnerability
of the research participant; the method must
be tailored for their protection
National Statement;
TCPS2
When requirements of free, informed,
ongoing consent cannot be met, vulnerable
participants ought to be involved in decision-
making, i.e. obtaining assent, asking about
their feelings regarding participation
TCPS2
Clinician-researchers must take care not to
overplay the benefits of research participation
to vulnerable patients, who may be misled to
enter research with false hope
TCPS2
Inducements that may not be excessive or
inappropriate for other participants may be
undue influences if the subject is especially
vulnerable
Belmont Report
Care should be taken in the informed
consent process to ensure that women
vulnerable to coercion have adequate time
and a proper environment in which to take
decisions
CIOMS
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vulnerable groups. While the provided definition fo-
cuses on vulnerability as stemming from an incapacity
to protect one’s own interests owing to both individual
and environmental features, vulnerability is also expli-
citly linked to justice-based concerns about the distri-
bution of the risks and benefits of research. The
identified implications of vulnerability thus correspond
to concerns relating to participants’ ability to provide
free and informed consent and relating to the appropri-
ateness of involving vulnerable participants in research.
There is a lack of clarity and consistency, however, in
the discussion of vulnerable groups. The CIOMS
guidelines distinguishes between three types of vulner-
able groups – those who are “conventionally considered
vulnerable”, those who are vulnerable due to social
pressures (i.e. persons in dependent relationship with
researchers, such as students or pharmaceutical em-
ployees), and “other groups or classes” ([18], p. 64) for
whom no explanation is provided and who do not, on
their face, bear a significant resemblance to these other
groups.
UNESCO Declaration The Declaration is concerned
with both a general “human vulnerability” and a more
particular “special vulnerability” ([19], Art. 8), neither of
which are defined. Its identification of personal, societal
and environmental conditions as sources of vulnerability
suggests a concept with wide-ranging concerns. The
Table 6 Implications of vulnerability, grouped by theme
(Continued)
Care should be taken in the informed
consent process for adults with mental health
problems or learning difficulties to ensure that
information is provided in the appropriate
format and that the roles and responsibilities




Additional consent from a parent or
guardian may be required for young people
who are vulnerable through immaturity in
ways that warrant this
National Statement
Researchers should invite participants in
dependent or unequal relationships to discuss
their participation with someone who can
support them in making their decision;
especially vulnerable participants in these




REBs must assess risks and benefits of
debriefing participants and whether debriefing
plan is appropriate for participants, especially
when they are vulnerable
TCPS2
REB research ethics board, CIOMS Council for International Organizations of
Medical Sciences, TCPS2 Tri-Council Policy Statement: Ethical Conduct for
Research Involving Humans, ICH GCP International Conference on Harmonisation,
Good Clinical Practice
Table 7 Major content areas of vulnerability addressed within each policy/guideline





concern(s) does vulnerability reflect?
Implications: How should we respond




– X X X
CIOMS X X X X
UNESCO
Declaration
– X X X
EU Clinical Trials
Directive
– X – X
EU Clinical Trials
Regulation
– X – X




– X X X




– X – X
Belmont Report – X X X
Common Rule – X – X
CIOMS Council for International Organizations of Medical Sciences, TCPS2 Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans, ICH GCP
International Conference on Harmonisation, Good Clinical Practice
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Declaration identifies respecting the personal integrity of
vulnerable groups as a key implication, suggesting that
vulnerability may consist, at least in part, of risks to one’s
personal integrity. Since concerns relating to vulnerability
are presented as fundamental principles, their interpret-
ation cannot be guided by other ethical principles.
EU Clinical Trials Directive The Clinical Trials Direct-
ive conveys a primarily consent-based vulnerability, with
children as the focus of its vulnerability-related regula-
tions. The implications it identifies focus on obtaining
proxy consent and assent, but also on the need to avoid fi-
nancial inducements for participation, suggesting a con-
cern for a risk of exploitation. Other implications include
a need to perform research with children in which group
benefits will be obtained and ensuring the interests of the
patient prevail over those of society. As such, in addition
to concerns relating to consent, the Directive implicitly re-
lates vulnerability to concerns with the distribution of the
benefits and burdens of research. The Directive does not
provide an ethics framework, so interpretation of this
guidance cannot be guided by ethical principles.
EU Clinical Trials Regulation The Clinical Trials Regu-
lation conveys a mixed concept of vulnerability, concerned
both with issues of consent and increased health risks.
While vulnerability is not defined and no explanation for
the vulnerability of listed groups is provided, they can be
grouped by those assumed to face issues of consent in re-
search (people affected by mental health disorders, mi-
nors, and incapacitated subjects) and those who may be at
greater physical (i.e. health) risks in research (frail or older
people, people suffering from chronic conditions, and
pregnant or breastfeeding women). The implications iden-
tified do not fall along this consent/health risk distinction,
however, with a need for research to improve treatments a
key implication for frail or older people, people with
chronic conditions, and people affected by mental health
disorders, and the need for special expertise in research
ethics review identified as a specific consideration for mi-
nors, incapacitated subjects, and pregnant or breastfeed-
ing women. No ethical framework is provided in the
Regulation to facilitate interpretation of this guidance.
ICH GCP These guidelines present a consent-based
concept of vulnerability that lacks internal clarity due to
its broad scope of vulnerable groups. Vulnerable subjects
are defined as those whose ability to provide voluntary
consent may be compromised by social pressures, and
the first category of groups listed is clearly linked to this
definition. However, it is not clear how the wide range of
'other vulnerable groups' relates to this definition or
which characteristics are thought to render them
vulnerable. The guidelines do not provide an ethical
framework to facilitate interpretation of the concept of
vulnerability.
National policies and guidelines
Australian National Statement The National State-
ment suggests a comprehensive conceptualisation of vul-
nerability relating to concerns about consent, fair
involvement in research, and a balance of risks and ben-
efits to participants. It favours a group-specific approach
to vulnerability, where this concept is discussed largely
in reference to specific groups. General statements about
vulnerability suggest that it is an important factor when
considering the appropriate method of consent. While
vulnerability is not defined, explanations for the vulner-
ability of all identified groups are provided and are dis-
cussed with reference to the Statement’s guiding ethical
principles. Interestingly, explanations of the vulnerability
of identified groups the principles from which obliga-
tions to those groups stem do not always line up. In
some cases, the relationship is clear; the vulnerability of
young persons originates in their lack of ability to pro-
vide consent and is linked to respect for persons, and
the vulnerability of neonates in intensive care originates
in the risks of long-term harms and is linked to benefi-
cence. However, while persons in pre-existing/dependent
relationships with researchers are said to face issues pro-
viding voluntary consent, the key implication relating to
this group is grounded in the principle of justice (i.e. en-
suring they are not over-researched). Similarly, while
persons with terminal illness are said to be vulnerable to
unrealistic expectations of benefit (i.e. may have a com-
promised ability to consent), the key response to this is
to balance the benefits and burdens of research and is
grounded in beneficence.
TCPS2 The TCPS2 presents an autonomy-based con-
ceptualisation of vulnerability that is comprehensive in
scope. The provided definition of vulnerability states
that it stems from a diminished ability to protect one’s
own interests caused by both individual (e.g. lack of
decision-making capacity) and environmental (e.g. lack
of access to social goods) factors. Importantly, vulner-
ability is said to be context-specific and dynamic, dis-
couraging assumptions of vulnerability based on group
membership. However, the policy still relies on the
identification of groups likely to be vulnerable, as well as
the identification of circumstances that can create
vulnerability for a participant. While the definition of
vulnerability itself is implicitly linked to the principle of
autonomy, obligations towards participants in vulnerable
circumstances are more comprehensive and are
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grounded in the principles of respect for persons, con-
cern for welfare and justice.
United Kingdom Research Governance Framework
The framework conveys a consent-based conceptualisa-
tion of vulnerability that is narrow in scope, labelling
adults who may have issues with understanding and
decision-making as vulnerable. Consistent with this, the
implications of vulnerability focus on providing partici-
pants with the necessary support in the informed con-
sent process. Since no ethical framework or principles
are discussed relative to vulnerability, these cannot be
used to facilitate interpretation of the guidance.
Belmont Report The Report conveys a consent-based
conceptualisation of vulnerability that lacks clarity in the
features of vulnerability it aims to target. It is assumed
that vulnerable subjects have a “dependent status and fre-
quently compromised capacity for free consent” ([26], Part
C. 3), which seems to form the basis of their vulnerability.
Special considerations about vulnerable subjects are dis-
cussed in reference to respect for persons (ordinary in-
ducements may be come undue influences for vulnerable
populations), beneficence (special justification is required
for research with vulnerable subjects) and justice (vulner-
able subjects must be protected from over-recruitment to
research).
Common Rule The Common Rule conveys a consent-
based conceptualisation of vulnerability that lacks internal
clarity regarding its scope. A number of groups are identi-
fied as vulnerable, including handicapped persons, but
while the other groups are said to be vulnerable to coer-
cion or undue influence, no explanation is provided for
handicapped persons. Similarly, the implications of vul-
nerability include concern for equitable subject selection
and the provision of additional safeguards, but handi-
capped persons are never associated with these protec-
tions. Without a definition of vulnerability, it is not clear
what special vulnerability handicapped persons may be
faced with in research.
Discussion
The objective of this analysis was to describe the concept
of vulnerability in research ethics policies and guidelines,
and to assess how it is conceptualised and operationalised.
All policies and guidelines employed the concept of vul-
nerability but very few define it. Instead, vulnerability is
most frequently discussed in terms of vulnerable groups,
with some attention given to the sources of vulnerability,
and the implications of conducting research with vulner-
able participants. In many respects the policies come out,
on the whole, as richer and more complex than some
scholarly analyses of the concept of vulnerability suggest
[6, 28, 29]. For example, the policies and guidelines iden-
tify sources of vulnerability that are both individual and
situational [29]; vulnerability can stem from a lack of cap-
acity or from one’s health status, but also from social pres-
sures that may impact one’s ability to make a free and
informed decision, consistent with some scholarly per-
spectives [30]. Responding to vulnerability requires cau-
tion and special consideration on the part of researchers
and REBs but, ultimately, the implications identified in
our study suggest that participant vulnerability need not
signal a need for exclusion from research. The few explicit
definitions in our sample define vulnerability as a defi-
ciency of the participant, as an inability to protect one’s in-
terests in research. The majority of other guidelines and
policies implicitly convey a similar conceptualisation of
vulnerability as a deficiency in a participant’s ability to
provide voluntary informed consent. Accordingly, even
though there is some diversity and richness in policies, it
tends to be scattered across multiple policies and relies on
implicit assumptions about the definition and nature of
vulnerability. Indeed, a significant analytic effort was re-
quired to bring structure to the data and yield the guid-
ance captured in this paper. We further discuss how our
findings relate to (1) previous critiques found in the schol-
arly literature and (2) the role of stakeholder engagement
in the process of refining the concept of vulnerability in
research ethics policies and guidance.
Previous critiques from the scholarly literature
Within the scholarly literature several critiques of vul-
nerability in research ethics guidelines have been voiced.
First, concerns have been raised that the manner in
which vulnerability is defined and operationalised in re-
search ethics governance stereotypes and reinforces
stigma about whole categories of individuals [9, 12, 31].
Our results reinforce these concerns, as the reliance on
listing groups of vulnerable persons is rampant. This la-
belling [6] or sub-population [30] approach does little to
bring attention to the importance of context and of
assessing the characteristics of individual research par-
ticipants beyond their membership in a group [5, 6, 9].
It is important to note that research protocols create
groups through sampling “regardless of whether the sam-
ple is drawn from a naturally occurring community” ([9],
p. 2221). Understanding this point underscores the fact
that group membership in this context may not well
capture the various relevant aspects (and potential vul-
nerabilities) in an individual participant’s situation. This
may result in inappropriate and ineffective protections
being applied in some protocols. Group listings may also
cause confusion due to the broadness of some labels
(e.g. persons with mental illness or mental health prob-
lems). Furthermore, it seems that the designation of
some groups as vulnerable may be based on
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assumptions not supported by evidence (e.g. the designa-
tion of pregnant women as vulnerable to coercion or undue
influence in the Common Rule).
Another major concern has been that vulnerability, as
conceived of in the guidelines, focuses overwhelmingly
on a lack of ability to consent [10], blinding researchers
and REBs to other relevant types of vulnerability, relat-
ing, for example, to an increased risk of exploitation [32]
or a lack of basic rights [33]. While vulnerability is rarely
defined, the majority of policies and guidelines convey
implicitly that vulnerability is fundamentally an inability
to provide free and informed consent. However, the im-
plications of vulnerability often move beyond consent,
addressing issues of fair subject selection and favourable
risk benefit assessments. In addition to providing explicit
definitions for what, exactly, is meant when the term
‘vulnerability’ is used, the clarity and usability of policies
and guidelines could be improved by ensuring that these
definitions clearly relate to the concerns with which vul-
nerability is associated.
Though they recognise both individual and contextual
sources of vulnerability, all policies and guidelines con-
veyed that vulnerability is a personal characteristic. Even
the TCPS2, with its notable emphasis on vulnerability as
a context-dependent feature, ultimately defines it as a
person’s inability to protect their own interests in re-
search. In contrast, a growing body of scholarly literature
converges around the notion that vulnerability is a rela-
tional feature, borne of power asymmetries between par-
ticipants and research staff, investigators and institutions
[10, 31, 34]. Adopting such a view in research ethics guide-
lines may better serve participants, encouraging measures
that would empower and promote their agency in the re-
search context [34]. Furthermore, the focus on research
participants neglects how research environments (e.g. the
existence of conflicts of interest) can actively contribute to
disempowering research participants/research subjects and
thus create the need for remediation that does not neces-
sarily concern the research participant per se [6, 10].
A need for evidence and stakeholder engagement to
refine research ethics policies and guidance on
vulnerability
Research ethics guidelines and policies typically stress the
importance of vulnerability. However, it has been argued
that vulnerability is not a substantive ethical concept in it-
self, serving only as a marker of other research ethics con-
cerns already captured by existing concepts such as harm
or consent [35]. This is certainly an important conceptual
concern, but what may be of greater relevance in the realm
of policy development is the degree to which the concept
of vulnerability is a useful, effective tool for those designing,
reviewing and conducting research [5, 6]. It may be the case
that vulnerability merely serves to signal concerns relating
to other pre-existing ethical concepts, but if these concerns
would be otherwise missed, the concept would then be
proven to have a vital practical function in research ethics.
A few authors have made explicit claims to that effect. For
example, Kipnis argues that vulnerability stems from im-
pairments to one’s ability to provide voluntary informed
consent. He identifies six types of vulnerability which all
signal potential issues with a participant’s ability to consent:
cognitive, deferential and medical vulnerability, all of which
relate to characteristics of the participant themselves, and
juridic, allocational and infrastructural vulnerability, all of
which relate to factors in the participant’s environment
[30]. These categories help bring attention to more specific
aspects that generate vulnerability. Luna argues that vulner-
ability, when conceived of as dynamic, flexible and inessen-
tial, can serve as “a fine grain tool to analyze, interpret, and
evaluate the research situation” ([6], p. 130). She proposes
that vulnerability be conceived of through the metaphor of
layers, in which different layers of vulnerability can operate
and interact within a given participant’s circumstances.
Luna’s account of vulnerability thus provides researchers
and REBs with a conceptual tool with which to examine a
research participant’s circumstances, identify potential vul-
nerabilities (e.g. relating to capacity or social pressure in the
consent process), and develop targeted strategies for their
remediation.
In spite of these more sophisticated proposals, there is
a dearth of empirical evidence on the functioning of re-
search ethics committees and outcomes of research eth-
ics policies and, to our knowledge, few studies have
examined the impact or understandings of the concept
of vulnerability based on research ethics guidelines and/
or more elaborate scholarly accounts. Empirical evidence
has shown that an understanding of vulnerability in the
context of research cannot be assumed to be universal –
in a study with Russian and Romanian research ethics
trainees, Loue and Loff [36] found that, at the initiation
of their training, their existing understanding of vulner-
ability varied considerably from conceptualisations in
the international guidelines. A study by Sengupta et al.
[37] gathered researchers’ perspectives on vulnerability
in HIV/AIDS clinical trials and on the Common Rule
guidance related to vulnerability and found that re-
searchers assessed vulnerability in relation to situational
factors that can render participants vulnerable, and that
they emphasised the need to assess vulnerability on a
case-by-case basis (i.e. rather than relying on a group-
based strategy). Taken together, these studies underscore
the need for policymakers to clearly delineate and define
the concerns vulnerability is intended to encompass, and
to assess the alignment of these views with those of re-
search stakeholders. Further, there is a need to assess the
outcomes of vulnerability-related guidance and policy
and to understand whether protections are actually
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effective and their impact on vulnerable participants
themselves. For example, there are crucial questions
about the actual usability and impact of such guidelines
as well as the potential need for mid-level guidance be-
tween general guidelines and the actual analyses of REBs
[38]. It has been suggested that more elaborate, on-the-
ground guidance on vulnerability would be beneficial to
help REBs direct their attention to the most pertinent
concerns [30]. In the process of developing such guid-
ance, the voices of those concerned by the application of
what sometimes appears as a label of vulnerability could
be instrumental in moving forward and avoiding the per-
petuation of stereotyping or stigmatising accounts of
vulnerability [34]. In this endeavour, the perspectives of
researchers and REBs, but also of research participants,
who seem to have been largely left out of the develop-
ment of research ethics guidelines, could be investigated.
Conclusion
Our in-depth analysis of human research ethics guidelines
and policies allowed us to analyse different perspectives on
the concept of vulnerability, including the definitions, justi-
fications, sources, and implications of vulnerability for re-
searchers and REBs. In some respects, this synthetic
account yielded a richer perspective than sometimes admit-
ted in scholarly literature. At the same time, there are con-
ceptual gaps within individual guidelines and policies that
require the attention of those charged with their develop-
ment. This lack of clarity could diminish the usability of the
guidance put forth in policies and therefore undermine its
impact on research practices. Policymakers should revisit
the concept of vulnerability to ensure each of its key com-
ponents is spelled out, and that these components are in-
ternally consistent (i.e. within individual guidelines).
Practically-oriented refinement of vulnerability could be fa-
cilitated by engaging research stakeholders and examining
the concrete impact of guidance and policy related to
vulnerability.
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